NCT02809820View on ClinicalTrials.gov

Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Carvedilol

Patients randomized to this group will receive carvedilol at the highest dose tolerated

DRUG

Metoprolol

Patients randomized to this group will receive metoprolol at the highest dose tolerated

Trial Locations (1)

80131

Federico II University of Naples, Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT02809820 - Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter